Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment

Histol Histopathol. 2023 Oct;38(10):1079-1097. doi: 10.14670/HH-18-608. Epub 2023 Mar 16.

Abstract

Solitary fibrous tumor (SFT) is a rare type of mesenchymal lesion with variable clinical presentation in which specific clinicopathologic factors have been related to patient outcome. SFT shares an important morphologic and immunohistochemical overlap with other sarcomas, hence the differential diagnosis is challenging. Although molecular studies provide significant clues, especially in the differential diagnosis with other neoplasms, a thorough hematoxylin and eosin analysis and the integration of phenotypical, clinical, and radiological features remain an essential tool in SFT diagnosis. In this review, we discuss some emerging issues still under debate in SFT.

Publication types

  • Review

MeSH terms

  • Animals
  • Diagnosis, Differential
  • Hemangiopericytoma* / diagnosis
  • Hemangiopericytoma* / pathology
  • Humans
  • Lizards*
  • Meningeal Neoplasms*
  • Risk Assessment
  • Soft Tissue Neoplasms* / diagnosis
  • Solitary Fibrous Tumors* / diagnosis
  • Solitary Fibrous Tumors* / genetics
  • Solitary Fibrous Tumors* / pathology